Cytotoxic activity evaluated against A549 tumor cells
|
Homo sapiens
|
5.3
nM
|
|
Cytotoxic Activity was evaluated against D54 tumor cells
|
Homo sapiens
|
60.0
nM
|
|
Inhibition of Pneumocystis carinii dihydrofolate reductase
|
None
|
42.0
nM
|
|
Inhibition of Pneumocystis carinii (pc) Dihydrofolate reductase
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibitory activity against pneumocystis carinii Dihydrofolate reductase
|
Pneumocystis carinii
|
10.0
nM
|
|
Inhibitory activity against Pneumocystis carinii dihydrofolate reductase.
|
Pneumocystis carinii
|
42.0
nM
|
|
Compound was tested for inhibition activity against pneumocystis carinii (Pneumocystis carinii) Dihydrofolate reductase
|
Pneumocystis carinii
|
42.0
nM
|
|
Concentration inhibiting Pneumocystis carinii dihydrofolate reductase
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibition of Pneumocystis carinii dihydrofolate reductase
|
Pneumocystis carinii
|
42.0
nM
|
|
In vitro inhibitory concentration against Pneumocystis carinii dihydrofolate reductase
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibition against Dihydrofolate reductase in Pneumocystis carinii
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibition of Dihydrofolate reductase of Pneumocystis carinii
|
Pneumocystis carinii
|
42.0
nM
|
|
Concentration required to inhibit the Toxoplasma gondii Dihydrofolate reductase by 50% was determined; Range: 8-30
|
Toxoplasma gondii
|
16.0
nM
|
|
Inhibition of dihydrofolate reductase from Toxoplasma gondii.
|
None
|
10.0
nM
|
|
Inhibitory activity against Dihydrofolate reductase from Pneumocystis carinii
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibitory activity against Dihydrofolate reductase from Pneumocystis carinii (pcDHFR)
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibition of dihydrofolate reductase DHFR in Pneumocystis carinii.
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibitory activity against dihydrofolate reductase (DHFR) from Pneumocystis carinii
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibitory activity against Dihydrofolate reductase from Pneumocystis carinii was evaluated using 90 uM dihydrofolic acid as substrate
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibitory activity against DHFR (Dihydrofolate reductase) from Pneumocystis carinii.
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibitory activity against Pneumocystis carinii Dihydrofolate reductase
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibitory activity against Pneumocystis carinii dihydrofolate reductase
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibitory activity against dihydrofolate reductase in Pneumocystis carinii at 37 centigrade.
|
Pneumocystis carinii
|
26.0
nM
|
|
Inhibitory concentration against Dihydrofolate reductase from Pneumocystis carinii (pc)
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibitory concentration against Pneumocystis carinii Dihydrofolate reductase
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibitory concentration against Pneumocystis carinii dihydrofolate reductase
|
Pneumocystis carinii
|
47.0
nM
|
|
Inhibitory concentration against dihydrofolate reductase dihydrofolate reductase from Pneumocystis carinii.
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibition of dihydrofolate reductase (DHFR) from Pneumocystis carinii(pc)
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibitory activity against purified dihydrofolate reductase from Pneumocystis carinii.
|
Pneumocystis carinii
|
42.0
nM
|
|
Binding affinity was reported with purified recombinant Pneumocystis carinii Dihydrofolate reductase
|
Pneumocystis carinii
|
0.71
nM
|
|
Inhibitory activity against Pneumocystis carinii dihydrofolate reductase (in 90 uM dihydrofolic acid)
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibition of Pneumocystis carinii dihydrofolate reductase
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibition of dihydrofolate reductase in pneumocystis carinii.
|
None
|
42.0
nM
|
|
Cytotoxic activity was evaluated against Daoy tumor cells
|
Homo sapiens
|
12.0
nM
|
|
Inhibitory activity against dihydrofolate reductase from pneumocystis carinii
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibition of Toxoplasma gondii dihydrofolate reductase
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibition of Toxoplasma gondii (tc) Dihydrofolate reductase
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibition of dihydrofolate reductase (DHFR) from Toxoplasma gondii(tg)
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibitory activity against Toxoplasma gondii (tg) Dihydrofolate reductase (DHFR)
|
Toxoplasma gondii
|
5.1
nM
|
|
Inhibitory activity against Toxoplasma gondii dihydrofolate reductase.
|
Toxoplasma gondii
|
10.0
nM
|
|
Compound was tested for inhibition activity against Toxoplasma gondii (Toxoplasma gondii) Dihydrofolate reductase
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibitory activity against dihydrofolate reductase from Toxoplasma gondii
|
Toxoplasma gondii
|
10.0
nM
|
|
Concentration inhibiting Toxoplasma gondii dihydrofolate reductase
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibition of Toxoplasma gondii dihydrofolate reductase
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibitory concentration against Toxoplasma gondii dihydrofolate reductase
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibition against Dihydrofolate reductase in Toxoplasma gondii
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibition of Dihydrofolate reductase of Toxoplasma gondii
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibitory activity against Dihydrofolate reductase from Toxoplasma gondii
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibitory activity against Dihydrofolate reductase from Toxoplasma gondii (tgDHFR)
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibitory activity against dihydrofolate reductase DHFR in Toxoplasma gondii.
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibitory activity against dihydrofolate reductase (DHFR) from Toxoplasma gondii
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibitory activity against Dihydrofolate reductase from Toxoplasma gondii was evaluated using 90 uM dihydrofolic acid as substrate
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibitory activity against DHFR (Dihydrofolate reductase) from Toxoplasma gondii.
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibitory activity against Toxoplasma gondii Dihydrofolate reductase
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibitory activity against Toxoplasma gondii dihydrofolate reductase
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibitory concentration against Dihydrofolate reductase from Toxoplasma gondii (tg)
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibitory concentration against Toxoplasma gondii Dihydrofolate reductase
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibitory concentration against Toxoplasma gondii dihydrofolate reductase
|
Toxoplasma gondii
|
16.0
nM
|
|
Inhibitory concentration against dihydrofolate reductase DHFR from Toxoplasma gondii
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibition of Toxoplasma gondii Dihydrofolate reductase
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibitory activity against purified Dihydrofolate reductase from Toxoplasma gondii.
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibitory activity against Toxoplasma gondii dihydrofolate reductase (in 90 uM dihydrofolic acid)
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibition of dihydrofolate reductase in Toxoplasma gondii.
|
None
|
10.0
nM
|
|
In vitro inhibition of human dihydrofolate reductase
|
None
|
1.0
nM
|
|
Inhibitory concentration against Dihydrofolate reductase from Mycobacterium avium (Mycobacterium avium)
|
Mycobacterium avium
|
1.5
nM
|
|
Inhibition of Dihydrofolate reductase from Pneumocystis carinii (Pneumocystis carinii)
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibitory activity against recombinant human Dihydrofolate reductase
|
None
|
18.0
nM
|
|
Inhibitory activity against human dihydrofolate reductase
|
Homo sapiens
|
90.0
nM
|
|
Tested for inhibitory activity against dihydrofolate reductase in human
|
None
|
1.4
nM
|
|
Tested for inhibitory concentration against human dihydrofolate reductase(DHFR)
|
None
|
12.2
nM
|
|
Inhibitory concentration against Dihydrofolate reductase from Toxoplasma gondii (Toxoplasma gondii)
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibitory concentration against Dihydrofolate reductase from rat liver
|
Rattus norvegicus
|
3.0
nM
|
|
Inhibition of dihydrofolate reductase in Candida albicans (in vitro).
|
Candida albicans
|
40.0
nM
|
|
Inhibition of Dihydrofolate reductase enzyme from Candida albicans
|
Candida albicans
|
1.9
nM
|
|
Inhibition of human recombinant Dihydrofolate reductase enzyme
|
None
|
1.4
nM
|
|
Inhibitory activity against Leu22-Phe mutant human Dihydrofolate reductase
|
None
|
83.0
nM
|
|
Inhibitory activity against recombinant Dihydrofolate reductase from Escherichia coli (ecDHFR)
|
Escherichia coli
|
10.0
nM
|
|
Inhibitory activity against Escherichia coli (ec) Dihydrofolate reductase
|
Escherichia coli
|
7.0
nM
|
|
Inhibitory activity against Dihydrofolate reductase from Lactobacillus casei
|
Lactobacillus casei
|
27.0
nM
|
|
Concentration required to inhibit the Mycobacterium avium Dihydrofolate reductase by 50% was determined; Range: 1.3-1.7
|
Mycobacterium avium
|
1.5
nM
|
|
Concentration required to inhibit the Pneumocystis carinii Dihydrofolate reductase by 50% was determined; Range: 34-66
|
Pneumocystis carinii
|
47.0
nM
|
|
Inhibition of dihydrofolate reductase from pneumocystis carinii.
|
None
|
42.0
nM
|
|
Inhibitory activity against Dihydrofolate reductase from Lactobacillus casei (lcDHFR)
|
Lactobacillus casei
|
260.0
nM
|
|
Compound was tested for inhibition activity against rat liver lipophilic Dihydrofolate reductase (DHFR).
|
None
|
3.0
nM
|
|
Inhibitory activity against dihydrofolate reductase from rat liver
|
None
|
3.0
nM
|
|
Concentration inhibiting rat liver dihydrofolate reductase.
|
None
|
3.0
nM
|
|
Concentration required to inhibit the rat liver Dihydrofolate reductase by 50% was determined; Range: 7.0-9.2
|
None
|
8.0
nM
|
|
Inhibition of rat liver dihydrofolate reductase
|
Rattus norvegicus
|
3.0
nM
|
|
In vitro inhibitory concentration against rat liver dihydrofolate reductase
|
None
|
3.0
nM
|
|
Inhibition against Dihydrofolate reductase in rat liver
|
None
|
3.0
nM
|
|
Inhibition of Dihydrofolate reductase (DHFR) of in rat liver
|
Rattus norvegicus
|
3.0
nM
|
|
Inhibitory activity against Dihydrofolate reductase from rat liver
|
None
|
3.0
nM
|
|
Inhibitory activity against Dihydrofolate reductase from rat liver (rlDHFR)
|
None
|
3.0
nM
|
|
Inhibitory activity against dihydrofolate reductase DHFR in rat liver
|
None
|
3.0
nM
|
|
Inhibition of dihydrofolate reductase from rat liver.
|
None
|
3.0
nM
|
|
Inhibitory activity against dihydrofolate reductase (DHFR) from rat liver
|
None
|
3.0
nM
|
|
Inhibitory activity against Dihydrofolate reductase from rat liver was evaluated using 90 uM dihydrofolic acid as substrate
|
None
|
3.0
nM
|
|
Inhibitory activity against DHFR (Dihydrofolate reductase) from Rat liver
|
None
|
3.0
nM
|
|
Inhibitory activity against rat liver dihydrofolate reductase
|
None
|
3.0
nM
|
|
Inhibitory activity against rat liver dihydrofolate reductase.
|
None
|
3.0
nM
|
|
Inhibitory activity against rat liver dihydrofolate reductase (in 90 uM dihydrofolic acid)
|
None
|
3.0
nM
|
|
Inhibitory activity against rat dihydrofolate reductase
|
None
|
8.0
nM
|
|
Inhibitory activity against rat liver Dihydrofolate reductase
|
None
|
3.0
nM
|
|
Inhibitory concentration against Dihydrofolate reductase from Rat liver (rl)
|
None
|
3.0
nM
|
|
Inhibitory concentration against Rat liver Dihydrofolate reductase
|
None
|
3.0
nM
|
|
Inhibitory concentration against dihydrofolate reductase DHFR from rat liver.
|
None
|
8.0
nM
|
|
Inhibition of rat liver dihydrofolate reductase
|
Rattus norvegicus
|
3.0
nM
|
|
Inhibition of rat liver Dihydrofolate reductase
|
Rattus norvegicus
|
3.0
nM
|
|
Inhibition of Dihydrofolate reductase of rat liver
|
Rattus norvegicus
|
3.0
nM
|
|
Inhibition of rat liver dihydrofolate reductase.
|
None
|
3.0
nM
|
|
Inhibition of dihydrofolate reductase (DHFR) from rat liver (rl)
|
None
|
3.0
nM
|
|
Inhibitory activity against purified dihydrofolate reductase from rat
|
None
|
3.0
nM
|
|
Inhibitory concentration against Mycobacterium avium dihydrofolate reductase
|
Mycobacterium avium
|
1.5
nM
|
|
Activity was evaluated against HCT-8 tumor cells
|
Homo sapiens
|
1.8
nM
|
|
Inhibition of 0.5-0.7 uM of U-46,619 induced [14C]5-HT secretion
|
Homo sapiens
|
750.0
nM
|
|
Cytotoxic activity was evaluated against L tumor cells
|
Mus musculus
|
4.7
nM
|
|
Inhibitory concentration against Lactobacillus casei
|
Lactobacillus casei
|
27.0
nM
|
|
Combined effect of active site mutation F31A and F34A on inhibitory effect for F31A/F34A murine dihydrofolate reductase (DHFR)
|
None
|
0.43
kcat/Km
|
|
Inhibitory constant for F31A/F34A murine dihydrofolate reductase (DHFR)
|
None
|
0.81
nM
|
|
Cytotoxic activity was evaluated against P388D1 tumor cells
|
Mus musculus
|
2.7
nM
|
|
Inhibition of 0.5-0.7 uM of U-46,619 induced human platelet aggregation
|
Homo sapiens
|
770.0
nM
|
|
Tested for inhibitory concentration against human SCC25 cell line
|
Homo sapiens
|
8.0
nM
|
|
Tested for inhibitory concentration against SCC-VII murine squamous carcinoma cell line
|
Mus musculus
|
6.3
nM
|
|
Inhibitory activity against Toxoplasma gondii cell growth(ca denotes calculated value)
|
Toxoplasma gondii
|
20.0
nM
|
|
Cytotoxic activity was evaluated against U87MG tumor cells
|
Homo sapiens
|
11.0
nM
|
|
Cytotoxic activity was evaluated against U373MG tumor cells
|
Homo sapiens
|
9.6
nM
|
|
Cytotoxic Activity was evaluated against Vero tumor cells
|
Chlorocebus sabaeus
|
16.0
nM
|
|
Inhibitory compound against Wild-type human DHFR.
|
None
|
13.0
nM
|
|
Combined effect of active site mutation F31A and F34A on inhibitory effect for murine Wild-type dihydrofolate reductase (DHFR)
|
None
|
1.58
kcat/Km
|
|
Inhibitory constant for murine Wild-type dihydrofolate reductase (DHFR)
|
None
|
0.06
nM
|
|
Selectivity ratio of IC50 for rat liver DHFR to IC50 for Toxoplasma gondii DHFR
|
None
|
0.3
|
|
Inhibition of Pneumocystis carinii DHFR using dihydrofolic acid substrate and NADPH cofactor
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibition of rat liver DHFR using dihydrofolic acid substrate and NADPH cofactor
|
Rattus norvegicus
|
3.0
nM
|
|
Inhibition of Mycobacterium avium DHFR using dihydrofolic acid substrate and NADPH cofactor
|
Mycobacterium avium
|
1.5
nM
|
|
Antiproliferative activity against human RFC expressing Chinese hamster PC43-10 cells
|
Cricetulus griseus
|
25.0
nM
|
|
Antiproliferative activity against human RFC expressing Chinese hamster R2 cells
|
Cricetulus griseus
|
6.7
nM
|
|
Antiproliferative activity against human FRalpha expressing Chinese hamster RT16 cells
|
Cricetulus griseus
|
13.0
nM
|
|
Antiproliferative activity against human FRalpha expressing Chinese hamster RT16 cells in presence of folic acid
|
Cricetulus griseus
|
4.1
nM
|
|
Antiproliferative activity against human FRbeta expressing Chinese hamster D4 cells
|
Cricetulus griseus
|
11.0
nM
|
|
Antiproliferative activity against human FRbeta expressing Chinese hamster D4 cells in presence of folic acid
|
Cricetulus griseus
|
6.1
nM
|
|
Antiproliferative activity against human RFC and FRalpha expressing human KB cells
|
Homo sapiens
|
58.0
nM
|
|
Antiproliferative activity against human RFC and FRalpha expressing human KB cells in presence of folic acid
|
Homo sapiens
|
155.0
nM
|
|
Antiproliferative activity against human RFC and FRalpha expressing human IGROV1 cells
|
Homo sapiens
|
12.0
nM
|
|
Antiproliferative activity against human RFC and FRalpha expressing human IGROV1 cells in presence of folic acid
|
Homo sapiens
|
8.6
nM
|
|
Inhibition of Pneumocystis carinii dihydrofolate reductase
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibition of rat liver dihydrofolate reductase
|
Rattus norvegicus
|
3.0
nM
|
|
Inhibition of Toxoplasma gondii dihydrofolate reductase
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibition of Mycobacterium avium DHFR at 37 degC by spectrophotometry
|
Mycobacterium avium
|
1.5
nM
|
|
Inhibition of Pneumocystis carinii DHFR at 37 degC by spectrophotometry
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibition of rat liver DHFR at 37 degC by spectrophotometry
|
Rattus norvegicus
|
3.0
nM
|
|
Inhibition of Toxoplasma gondii DHFR at 37 degC by spectrophotometry
|
Toxoplasma gondii
|
10.0
nM
|
|
Inhibition of Trypanosoma cruzi DHFR by spectrophotometric assay
|
Trypanosoma cruzi
|
20.2
nM
|
|
Inhibition of Trypanosoma cruzi DHFR by spectrophotometric assay
|
Trypanosoma cruzi
|
6.6
nM
|
|
Inhibition of human DHFR by spectrophotometric assay
|
Homo sapiens
|
80.9
nM
|
|
Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum V1S expressing DHFR quadruple mutant with point mutations at codons 108, 51, 59 and 164 gene by [3H]hypoxanthine incorporation assay
|
Plasmodium falciparum
|
24.8
nM
|
|
Antimalarial activity against pyrimethamine-sensitive Plasmodium falciparum 3D7 expressing wild type DHFR by [3H]hypoxanthine incorporation assay
|
Plasmodium falciparum
|
1.9
nM
|
|
Antimalarial activity against Plasmodium falciparum Kenyan isolates by [3H]hypoxanthine incorporation assay
|
Plasmodium falciparum
|
30.0
nM
|
|
Antimalarial activity against Plasmodium falciparum Kenyan isolates expressing DHFR Ser108Asn and Cys59Arg or Ser108Asn and Asn51Ile double mutant by [3H]hypoxanthine incorporation assay
|
Plasmodium falciparum
|
40.92
nM
|
|
Antimalarial activity against Plasmodium falciparum Kenyan isolates expressing DHFR Ser108Asn, Asn51Ile and Cys59Arg triple mutant by [3H]hypoxanthine incorporation assay
|
Plasmodium falciparum
|
20.91
nM
|
|
Antimalarial activity against Plasmodium falciparum isolate Kil-164 expressing DHFR Ser108Asn, Asn51Ile, Cys59Arg and Ile164Leu quadruple mutant by [3H]hypoxanthine incorporation assay
|
Plasmodium falciparum
|
44.66
nM
|
|
Inhibition of Mycobacterium avium DHFR
|
Mycobacterium avium
|
1.5
nM
|
|
Inhibition of Pneumocystis carinii DHFR
|
Pneumocystis carinii
|
42.0
nM
|
|
Inhibition of rat liver DHFR
|
Rattus norvegicus
|
3.0
nM
|
|
Inhibition of Pneumocystis jirovecii recombinant DHFR
|
Pneumocystis jirovecii
|
2.1
nM
|
|
Inhibition of human recombinant DHFR
|
Homo sapiens
|
2.6
nM
|
|
Inhibition of Pneumocystis jirovecii DHFR expressed in Escherichia coli Rosetta-gami B (DE3) assessed as reduction in consumption of NADPH using 18 uM DHFA as substrate
|
Pneumocystis jirovecii
|
2.1
nM
|
|
Inhibition of recombinant human DHFR assessed as reduction in consumption of NADPH using 18 uM DHFA as substrate
|
Homo sapiens
|
2.6
nM
|
|
Inhibition of Toxoplasma gondii DHFR-TS expressed in Escherichia coli BL21 competent cells using DHF as substrate preincubated for 15 mins followed by substrate and NADPH addition and measured after 60 mins by resazurin dye based diaphorase-coupled assay
|
Toxoplasma gondii
|
1.35
nM
|
|
Inhibition of human DHFR expressed in Escherichia coli BL21 competent cells using DHF as substrate preincubated for 15 mins followed by substrate and NADPH addition and measured after 60 mins by resazurin dye based diaphorase-coupled assay
|
Homo sapiens
|
4.07
nM
|
|
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate
|
Severe acute respiratory syndrome coronavirus 2
|
-0.6
%
|
|
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging
|
Chlorocebus sabaeus
|
58.28
%
|
|
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging
|
Chlorocebus sabaeus
|
58.28
%
|
|
Determination of IC50 values for inhibition of SARS-CoV-2 induced cytotoxicity of VERO-E6 cells after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging
|
Chlorocebus sabaeus
|
330.0
nM
|
|
Determination of IC50 values for inhibition of SARS-CoV-2 induced cytotoxicity of VERO-E6 cells after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging
|
Chlorocebus sabaeus
|
330.0
nM
|
|